Endoscopic Quality Improvement Program

Adenomatous Polyps Clinical Trial

— EQUIP  

Official title:

The Effect of an Intensive Endoscopic Quality Improvement Program (EQUIP) on Improved Detection and Classification of Non-polypoid (Flat and Depressed) and Polypoid Colorectal Adenomas. ("EQUIP" Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01415817
• Other study ID #: 10-000433
• Status: Completed
• Phase: N/A
• Start date: August 2010
• Est. completion date: April 2011

Study information

• Verified date: May 2023
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Effective colorectal cancer (CRC) screening relies on early identification and removal of both polypoid and non-polypoid lesions with neoplastic potential. The investigators hypothesize that an intensive training program designed to enhance both recognition and classification of lesions with neoplastic potential, will result in an increase in non-polypoid adenoma detection in addition to and independent of an increase in overall adenoma detection rates.

Description:

Our Endoscopic Quality Improvement Program (EQUIP) was a prospective educational intervention with our staff endoscopist as our study population. The investigators measured adenoma detection rates for a baseline period then randomly assigned half of the endoscopists to undergo EQUIP training. The investigators then examined baseline and post-training study adenoma detection rates (ADR's) for all endoscopist (trained and un-trained) to evaluate the impact of training.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: April 2011
• Est. primary completion date: December 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Colonoscopies performed at Mayo clinic ambulatory surgical center

Exclusion Criteria:

• Procedures for the indication of acute GI hemorrhage

• Active colitis

• Hereditary polyposis syndrome

• Inflammatory bowel disease

• Incomplete procedures

• Procedures with surgically altered anatomy (i.e. prior colectomy)

• Poor bowel preparation (Boston Bowel preparation score <5) were also excluded.

Related Conditions & MeSH terms

• Adenomatous Polyps
• Colorectal Polyps
• Polyps

Intervention

Other:
• Training session
Series of two training sessions after the first phase of study followed by monthly feedback.

Locations

Country	Name	City	State
United States	Mayo Clinic Florida	Jacksonville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measurement of overall adenoma detection rate	Primary outcome measures will include overall and per patient adenoma detection rate for polypoid and non polypoid neoplastic lesions.	1 year
Secondary	Measurement of total polypectomy rate	Secondary outcomes will include total polypectomy rate (hyperplastic vs. adenoma),	1 Year
Secondary	Measurement of colonoscopy time	Total colonoscopy time and endoscopist acceptance. Variables such as patient demographics and prep quality will be adjusted for.	1 Year
Secondary	Endoscopist Acceptance	Ensdoscopist acceptance rate will be measured. Variables such as patient demographics and prep quality will be adjusted for.	1 Year